Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.175 (-18.92%)
Bid:
0.70
Ask:
0.80
Spread: 0.10 (14.286%)
Market Cap: £1.83m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

Director/PDMR Shareholding

17 Feb 2025 07:00

Acuity RM Group Plc - Director/PDMR Shareholding

Acuity RM Group Plc - Director/PDMR Shareholding

PR Newswire

LONDON, United Kingdom, February 17

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

17 February 2025

 

Acuity RM Group plc

("Acuity" or the "Company")

Director Share purchases

Acuity (AIM:ACRM), the software group, is pleased to announce that on 14 February 2025, Angus Forrest, Chairman and David Rajakovich, Chief Executive, bought Ordinary Shares in the market as shown in the table below.

 

 

Name

Number of shares purchased

Average price paid

Total number of shares held

Approximate percentage of the issued share capital %

Angus Forrest

500,000

1.950p

5,925,841

3.95%

David Rajakovich

2,500,000

1.938p

2,500,000

1.66%

 

Further information on the purchases is shown below.

 

 

Enquiries:

For further information: 

Acuity RM Group plc

020 3582 0566

Angus Forrest, Chairman

https://www.acuityrmgroup.com

 

Zeus (NOMAD & Joint Broker)

https://www.zeuscapital.co.uk

Mike Coe / James Bavister

020 3829 5000

 

Peterhouse Capital Limited (Joint Broker)

020 7469 0936

Lucy Williams / Duncan Vasey

 

Clear Capital Markets Limited (Joint Broker)Bob Roberts

020 3869 6080

 

Note to Editors

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services, focused on cybersecurity. Its award-winning software platform, STREAM®, which collects and analyses data about organisations to improve business decisions and management, is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

The Company is focused on delivering long term, sustainable growth in shareholder value from organic growth and complementary acquisitions.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Angus Forrest

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Acuity RM Group plc

b)

LEI

213800JHJFKALDJA5X97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.1p each

 

 

 

GB00BR0WHY71

b)

Nature of the transaction

Purchase in the Market

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.950p

500,000

d)

Aggregated information

- Aggregated volume

- Price

 

500,000

£9,750.00

e)

Date of the transaction

14 February 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Rajakovich

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Acuity RM Group plc

b)

LEI

213800JHJFKALDJA5X97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.1p each

 

 

 

GB00BR0WHY71

b)

Nature of the transaction

Purchase in the Market

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.938p

2,500,000

d)

Aggregated information

- Aggregated volume

- Price

 

2,500,000

48,450.00

e)

Date of the transaction

14 February 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

 



12
Date   Source Headline
17th Jun 20267:00 amPRNRetail Offer
16th Jun 20264:33 pmRNSFundraise of approximately £400,000
8th Jun 20267:00 amRNS-RContract Expansion
24th Apr 20267:00 amPRNTrading Statement
23rd Apr 20267:00 amPRNTrading Statement
27th Mar 20267:00 amPRNIssue of Equity
16th Mar 20267:00 amRNSProduct Launch
16th Mar 20267:00 amPRNProduct Launch
9th Mar 20267:00 amRNS-RA client’s experience of Acuity
24th Feb 20267:00 amRNS-RContract win
17th Feb 20267:00 amPRNContract
5th Feb 20262:35 pmPRNDirector/PDMR Shareholding
5th Feb 20261:17 pmPRNPDMR Shareholding
4th Feb 20267:00 amPRNHolding in Company
2nd Feb 20267:00 amPRNContract
15th Jan 20268:07 pmPRNHoldings in Company and Director Dealing
15th Jan 20267:00 amPRNStatement re Investor Presentation 10.00am 21 January
13th Jan 20267:00 amPRNTrading Statement
18th Nov 20258:47 amRNSHolding(s) in Company
17th Nov 20257:00 amPRNStatement re sale of investment
13th Nov 20254:06 pmPRNHolding(s) in Company
12th Nov 20257:00 amPRNDirectorate changes
21st Oct 20257:00 amRNS-RContract Win
7th Oct 20257:00 amPRNContract
22nd Sep 20257:00 amPRNIssue of Equity
16th Sep 20251:03 pmPRNHolding(s) in Company
5th Sep 20257:00 amPRNStatement re Investor presentation 10.00am 11 September
2nd Sep 20257:00 amPRNHalf-year Report
18th Aug 20257:00 amRNS-RFirst customer win for new product
30th Jul 20251:52 pmPRNResult of AGM
29th Jul 20257:00 amPRNIssue of Equity
11th Jul 202511:33 amPRNHolding(s) in Company
7th Jul 20254:09 pmPRNAnnual Report and Notice of AGM
7th Jul 202512:23 pmPRNHolding(s) in Company
7th Jul 20257:00 amPRNProduct Launch
4th Jul 202511:56 amPRNHolding(s) in Company
2nd Jul 20257:00 amPRNStatement re Final Results
30th Jun 20251:54 pmPRNIssue of Equity
26th Jun 20256:04 pmPRNHolding(s) in Company
25th Jun 20259:30 amRNSFinal Results
19th Jun 20253:22 pmPRNHolding(s) in Company
13th Jun 202510:30 amPRNStatement re Business and Directorate
21st May 20257:00 amPRNIssue of Equity
19th May 20259:45 amPRNIssue of Equity
19th May 20257:00 amPRNIssue of Equity
6th Mar 20257:00 amPRNStatement re Investor Presentation
17th Feb 20257:00 amPRNDirector/PDMR Shareholding
7th Feb 20257:00 amPRNChanges in share options
5th Feb 20258:59 amPRNCorrection to Year end Update
4th Feb 20257:00 amPRNTrading Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.